These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 9255199
21. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Transplantation; 2012 Jan 15; 93(1):73-81. PubMed ID: 22129761 [Abstract] [Full Text] [Related]
22. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children. Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH. Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323 [Abstract] [Full Text] [Related]
23. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan. Hsu CT, Chang MH, Ho MC, Chang HH, Lu MY, Jou ST, Ni YH, Chen HL, Hsu HY, Wu JF. J Formos Med Assoc; 2019 Nov 15; 118(11):1537-1545. PubMed ID: 30630698 [Abstract] [Full Text] [Related]
24. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. McVicar JP, Kowdley KV, Emond MJ, Barr D, Marsh CL, Carithers RL, Perkins JD. Clin Transplant; 1997 Aug 15; 11(4):328-33. PubMed ID: 9267724 [Abstract] [Full Text] [Related]
25. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. McLaughlin K, Wajstaub S, Marotta P, Adams P, Grant DR, Wall WJ, Jevnikar AM, Rizkalla KS. Liver Transpl; 2000 Sep 15; 6(5):570-4. PubMed ID: 10980055 [Abstract] [Full Text] [Related]
26. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C. Kim RD, Fujikawa T, Mizuno S, Schwartz JJ, Sorensen JB, Hemming AW, Fujita S. Eur J Gastroenterol Hepatol; 2011 Jul 15; 23(7):559-65. PubMed ID: 21555941 [Abstract] [Full Text] [Related]
31. One hundred children treated with tacrolimus after primary orthotopic liver transplantation. McDiarmid S, Goss J, Seu P, Shackleton C, Vargas J, Ament M, Busuttil R. Transplant Proc; 1998 Jun 15; 30(4):1397-8. PubMed ID: 9636564 [No Abstract] [Full Text] [Related]
32. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, Fung J, Reyes J. Transplantation; 2000 Aug 27; 70(4):617-25. PubMed ID: 10972220 [Abstract] [Full Text] [Related]
33. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT. Transplant Proc; 2010 Jun 27; 42(5):1763-8. PubMed ID: 20620519 [Abstract] [Full Text] [Related]
36. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Fridell JA, Jain A, Reyes J, Biederman R, Green M, Sindhi R, Mazariegos GV. Transplantation; 2002 Dec 27; 74(12):1721-4. PubMed ID: 12499888 [Abstract] [Full Text] [Related]